Search
Capsaicin
go.drugbank.com/drugs/DB06774ApprovedInvestigationalThe most recent capsaicin FDA approval was Qutenza, an 8% capsaicin patch dermal-delivery system, indicated for neuropathic pain associated with post-herpetic neuralgia.
Mixtures: NuDroxiPAK E-400, Trubrexa Patch ERSynonyms: (E)-8-Methyl-N-vanillyl-6-nonenamideIchthammol
go.drugbank.com/drugs/DB11341ApprovedIchthammol is also referred to as ammonium bituminosulfonate or ammonium bituminosulphonate. It is an ammonium salt of dark sulfonated shale oil (bituminous schists) produced via distillation of the oil followed by sulfonation and neutra...
Products: İHTİYOL ES HEALTH PHARMA % 10 MERHEM, 20 GArsenic trioxide
go.drugbank.com/drugs/DB01169ApprovedInvestigationalArsenic trioxide is a chemotherapeutic agent of idiopathic function used to treat leukemia that is unresponsive to first line agents. It is suspected that arsenic trisulfide induces cancer cells to undergo apoptosis. In general, arsenic ...
Products: ARSENICO TRIOSSIDO EGLatanoprost
go.drugbank.com/drugs/DB00654ApprovedInvestigationalIt was initially approved by the FDA in 1998. Latanoprost is the first topical prostaglandin F2 alpha analog used for glaucoma treatment.
Mixtures: LATANOPROST E TIMOLOLO EG, LATANOPROST E TIMOLOLO EGProducts: LATANOPROST EG, MONOPROST 50UG/ML EDVardenafil
go.drugbank.com/drugs/DB00862Approved[A258318] The FDA approved the use of vardenafil for the treatment of erectile dysfunction in 2003.
Products: VARDENAFIL EG, VARDENAFIL EG STADALercanidipine
go.drugbank.com/drugs/DB00528ApprovedInvestigationalWithdrawnLercanidipine is a calcium channel blocker of the dihydropyridine class. It is sold under various commercial names including Zanidip.
Mixtures: ZANIPRESS 10MG/10MG FTA, ZANIPRESS 20MG/10MG FTAProducts: LERCANIDIPINA EGDeflazacort
go.drugbank.com/drugs/DB11921ApprovedIt is marketed by Marathon Pharmaceuticals and was approved in February 2017 by the FDA.
Products: DEFLAZACORT EGEletriptan
go.drugbank.com/drugs/DB00216ApprovedInvestigationalEletriptan is a second generation triptan drug developed by Pfizer Inc for the treatment of migraine headaches.
Products: ELETRIPTAN EG